Neurooncology clinical trial design for targeted therapies: Lessons learned from the North American Brain Tumor Consortium

The North American Brain Tumor Consortium (NABTC) is a multi-institutional consortium with the primary objective of evaluating novel therapeutic strategies through early phase clinical trials. The NABTC has made substantial changes to the design and methodology of its trials since its inception in 1...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chang, Susan M., Lamborn, Kathleen R., Kuhn, John G., Yung, W.K. Alfred, Gilbert, Mark R., Wen, Patrick Y., Fine, Howard A., Mehta, Minesh P., DeAngelis, Lisa M., Lieberman, Frank S., Cloughesy, Timothy F., Robins, H. Ian, Abrey, Lauren E., Prados, Michael D.
Formato: Artigo
Lenguaje:Inglês
Publicado: Duke University Press 2008
Materias:
Review
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2666238/
https://ncbi.nlm.nih.gov/pubmed/18559968
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1215/15228517-2008-021
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares